{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:53:40Z","timestamp":1775699620193,"version":"3.50.1"},"reference-count":129,"publisher":"European Respiratory Society (ERS)","issue":"5","funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["TF-2016-11"],"award-info":[{"award-number":["TF-2016-11"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,3,11]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>The International Standards for Tuberculosis Care define the essential level of care for managing patients who have or are presumed to have tuberculosis, or are at increased risk of developing the disease. The resources and capacity in the European Union (EU) and the European Economic Area permit higher standards of care to secure quality and timely TB diagnosis, prevention and treatment. On this basis, the European Union Standards for Tuberculosis Care (ESTC) were published in 2012 as standards specifically tailored to the EU setting. Since the publication of the ESTC, new scientific evidence has become available and, therefore, the standards were reviewed and updated.<\/jats:p><jats:p>A panel of international experts, led by a writing group from the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC), updated the ESTC on the basis of new published evidence. The underlying principles of these patient-centred standards remain unchanged. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and comorbidities, and public health and prevention.<\/jats:p><jats:p>The ESTC target clinicians and public health workers, provide an easy-to-use resource and act as a guide through all the required activities to ensure optimal diagnosis, treatment and prevention of TB.<\/jats:p>","DOI":"10.1183\/13993003.02678-2017","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T15:35:14Z","timestamp":1524238514000},"page":"1702678","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["ERS\/ECDC Statement: European Union standards for tuberculosis care, 2017\u00a0update"],"prefix":"10.1183","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-574X","authenticated-orcid":false,"given":"Giovanni Battista","family":"Migliori","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-4474","authenticated-orcid":false,"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[]},{"given":"Senia","family":"Rosales-Klintz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8551-3598","authenticated-orcid":false,"given":"Rosella","family":"Centis","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-5777","authenticated-orcid":false,"given":"Lia","family":"D'Ambrosio","sequence":"additional","affiliation":[]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[]},{"given":"Graham","family":"Bothamley","sequence":"additional","affiliation":[]},{"given":"Jose Antonio","family":"Caminero","sequence":"additional","affiliation":[]},{"given":"Daniela Maria","family":"Cirillo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0025-6607","authenticated-orcid":false,"given":"Masoud","family":"Dara","sequence":"additional","affiliation":[]},{"given":"Gerard","family":"de Vries","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-4531","authenticated-orcid":false,"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[]},{"given":"Anh Tuan","family":"Dinh-Xuan","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Fabio","family":"Midulla","sequence":"additional","affiliation":[]},{"given":"Ivan","family":"Solovic","sequence":"additional","affiliation":[]},{"given":"Dragan R.","family":"Subotic","sequence":"additional","affiliation":[]},{"given":"Massimo","family":"Amicosante","sequence":"additional","affiliation":[]},{"given":"Ana Maria","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Andra","family":"Cirule","sequence":"additional","affiliation":[]},{"given":"Gina","family":"Gualano","sequence":"additional","affiliation":[]},{"given":"Heinke","family":"Kunst","sequence":"additional","affiliation":[]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[]},{"given":"Vija","family":"Riekstina","sequence":"additional","affiliation":[]},{"given":"Simon","family":"Tiberi","sequence":"additional","affiliation":[]},{"given":"Remi","family":"Verduin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8021-1358","authenticated-orcid":false,"given":"Marieke J.","family":"van der Werf","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"2024102100263690000_51.5.1702678.1","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2018\u20132016 data. Stockholm, European Centre for Disease Prevention and Control, 2018. Available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/ecdc-tuberculosis-surveillance-monitoring-Europe-2018-19mar2018.pdf"},{"key":"2024102100263690000_51.5.1702678.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00214014"},{"key":"2024102100263690000_51.5.1702678.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00198813"},{"key":"2024102100263690000_51.5.1702678.4","doi-asserted-by":"crossref","first-page":"20733","DOI":"10.2807\/1560-7917.ES2014.19.10.20733","article-title":"Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012","volume":"19","author":"van der Werf","year":"2014","journal-title":"Euro Surveill"},{"key":"2024102100263690000_51.5.1702678.5","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1097\/QAD.0000000000001252","article-title":"Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles","volume":"30","author":"van der Werf","year":"2016","journal-title":"AIDS"},{"key":"2024102100263690000_51.5.1702678.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01758-2017"},{"key":"2024102100263690000_51.5.1702678.7","doi-asserted-by":"crossref","first-page":"20583","DOI":"10.2807\/ese.18.37.20583-en","article-title":"First joint meeting of three European tuberculosis networks","volume":"18","author":"van der Werf","year":"2013","journal-title":"Euro Surveill"},{"key":"2024102100263690000_51.5.1702678.8","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00203811"},{"key":"2024102100263690000_51.5.1702678.9","unstructured":"Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC). 2nd edn. The Hague, Tuberculosis Coalition for Technical Assistance, 2009."},{"key":"2024102100263690000_51.5.1702678.10","unstructured":"TB CARE I. International Standards for Tuberculosis Care. 3rd edn. The Hague, TB CARE, 2014."},{"key":"2024102100263690000_51.5.1702678.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00094211"},{"key":"2024102100263690000_51.5.1702678.12","unstructured":"World Health Organization. Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis. Geneva, World Health Organization, 2017."},{"key":"2024102100263690000_51.5.1702678.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00216613"},{"key":"2024102100263690000_51.5.1702678.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01459-2016"},{"key":"2024102100263690000_51.5.1702678.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00170411"},{"key":"2024102100263690000_51.5.1702678.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00084906"},{"key":"2024102100263690000_51.5.1702678.17","unstructured":"World Health Organization Regional Office for Europe. Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies. Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region. Copenhagen, WHO Regional Office for Europe, 2017."},{"key":"2024102100263690000_51.5.1702678.18","unstructured":"European Centre for Disease Prevention and Control. Handbook on TB laboratory diagnostic methods for the European Union. Stockholm, ECDC, 2016."},{"key":"2024102100263690000_51.5.1702678.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00019410"},{"key":"2024102100263690000_51.5.1702678.20","unstructured":"World Health Organization, European Respiratory Society. Framework towards tuberculosis elimination in low-incidence countries. Geneva, World Health Organization, 2014."},{"key":"2024102100263690000_51.5.1702678.21","unstructured":"World Health Organization Regional Office for Europe. Roadmap to implement the tuberculosis action plan for the European Region 2016\u20132020. Towards ending tuberculosis and multidrug-resistant tuberculosis. Copenhagen, WHO Regional Office for Europe, 2016."},{"key":"2024102100263690000_51.5.1702678.22","unstructured":"World Health Organization. Implementing the end TB strategy: the essentials. Geneva, World Health Organization, 2015."},{"key":"2024102100263690000_51.5.1702678.23","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis \u2013 2013 revision. Geneva, Word Health Organization, 2013."},{"key":"2024102100263690000_51.5.1702678.24","unstructured":"World Health Organization. Implementing tuberculosis diagnostics. Policy framework. Geneva, World Health Organization, 2015."},{"key":"2024102100263690000_51.5.1702678.25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw694"},{"key":"2024102100263690000_51.5.1702678.26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw376"},{"key":"2024102100263690000_51.5.1702678.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01356-2016"},{"key":"2024102100263690000_51.5.1702678.28","unstructured":"World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis: 2016 update. Geneva, World Health Organization, 2016."},{"key":"2024102100263690000_51.5.1702678.29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02308-2016"},{"key":"2024102100263690000_51.5.1702678.30","unstructured":"World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Geneva, World Health Organization, 2017."},{"key":"2024102100263690000_51.5.1702678.31","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. 2015."},{"key":"2024102100263690000_51.5.1702678.32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01245-2015"},{"key":"2024102100263690000_51.5.1702678.33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-8-15"},{"key":"2024102100263690000_51.5.1702678.34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00201609"},{"key":"2024102100263690000_51.5.1702678.35","unstructured":"European Respiratory Society, European Lung Foundation. Lung Health in Europe Facts and Figures. Loddenkemper R , Gibson G , Sibille Y , eds. Sheffield, European Respiratory Society, 2003."},{"key":"2024102100263690000_51.5.1702678.36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2807\/esm.05.10.00033-en","article-title":"European recommendations on surveillance of antituberculosis drug resistance","volume":"5","author":"Schwoebel","year":"2000","journal-title":"Euro Surveill"},{"key":"2024102100263690000_51.5.1702678.37","unstructured":"World Health Organization. Multidrug and extensively drug-resistant TB (M\/XDR-TB) : 2010 global report on surveillance and response. Geneva, World Health Organization, 2010."},{"key":"2024102100263690000_51.5.1702678.38","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76"},{"key":"2024102100263690000_51.5.1702678.39","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00062-6"},{"key":"2024102100263690000_51.5.1702678.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.12.010"},{"key":"2024102100263690000_51.5.1702678.41","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00115514"},{"key":"2024102100263690000_51.5.1702678.42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00543-2016"},{"key":"2024102100263690000_51.5.1702678.43","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00812-17"},{"key":"2024102100263690000_51.5.1702678.44","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01075-2016"},{"key":"2024102100263690000_51.5.1702678.45","first-page":"CD010705","article-title":"GenoType(R) MTBDRsl assay for resistance to second-line anti-tuberculosis drugs","volume":"9","author":"Theron","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102100263690000_51.5.1702678.46","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03205-15"},{"key":"2024102100263690000_51.5.1702678.47","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00061808"},{"key":"2024102100263690000_51.5.1702678.48","doi-asserted-by":"crossref","first-page":"TBTB2-0019-2016","DOI":"10.1128\/microbiolspec.TBTB2-0019-2016","article-title":"Tuberculosis diagnostics: state of the art and future directions","volume":"4","author":"Pai","year":"2016","journal-title":"Microbiol Spectr"},{"key":"2024102100263690000_51.5.1702678.49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907847"},{"key":"2024102100263690000_51.5.1702678.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60438-8"},{"key":"2024102100263690000_51.5.1702678.51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","article-title":"Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study","volume":"4","author":"Pankhurst","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102100263690000_51.5.1702678.52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(17)30123-8","article-title":"Tuberculosis is changing","volume":"17","author":"Walker","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2024102100263690000_51.5.1702678.53","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01354-2017"},{"key":"2024102100263690000_51.5.1702678.54","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00073611"},{"key":"2024102100263690000_51.5.1702678.55","unstructured":"National Instititute for Health and Care Excellence. Tuberculosis (NG33). London, NICE, 2016."},{"key":"2024102100263690000_51.5.1702678.56","unstructured":"World Health Organization. Toman's tuberculosis. Case detection, treatment, and monitoring- questions and answers. Frieden T , ed. Geneva, World Health Organization, 2004."},{"key":"2024102100263690000_51.5.1702678.57","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1016\/S2214-109X(17)30201-2","article-title":"Comparison of sputum collection methods for tuberculosis diagnosis: a systematic review and pairwise and network meta-analysis","volume":"5","author":"Datta","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2024102100263690000_51.5.1702678.58","unstructured":"World Health Organization. Rapid Advice: Treatment of Tuberculosis in Children. Geneva, World Health Organization, 2010."},{"key":"2024102100263690000_51.5.1702678.59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1001CI"},{"key":"2024102100263690000_51.5.1702678.60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1092OC"},{"key":"2024102100263690000_51.5.1702678.61","unstructured":"European Centre for Disease Prevention and Control. Use of interferon-gamma release assays in support of TB diagnosis. Stockholm, ECDC, 2011."},{"key":"2024102100263690000_51.5.1702678.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30729-2"},{"key":"2024102100263690000_51.5.1702678.63","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00115110"},{"key":"2024102100263690000_51.5.1702678.64","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00114810"},{"key":"2024102100263690000_51.5.1702678.65","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01012-2016"},{"key":"2024102100263690000_51.5.1702678.66","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2016.6568"},{"key":"2024102100263690000_51.5.1702678.67","unstructured":"World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd edn. Geneva, World Health Organization, 2014."},{"key":"2024102100263690000_51.5.1702678.68","unstructured":"World Health Organization. Report of a WHO consultation on strengthening the active engagement of civil society organizations in the global TB prevention, care and control efforts. Geneva, World Health Organization, 2010. Report No.: WHO\/HTM\/TB\/2010.15."},{"key":"2024102100263690000_51.5.1702678.69","unstructured":"World Care Council. Patients\u2019 Charter for Tuberculosis Care. Viols en Laval, World Care Council, 2006."},{"key":"2024102100263690000_51.5.1702678.70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040238"},{"key":"2024102100263690000_51.5.1702678.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02124-3"},{"key":"2024102100263690000_51.5.1702678.72","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00462-2016"},{"key":"2024102100263690000_51.5.1702678.73","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1164\/rccm.201606-1097LE","article-title":"Limited benefit of the new shorter multidrug-resistant tuberculosis regimen in europe","volume":"194","author":"Lange","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102100263690000_51.5.1702678.74","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01249-2016"},{"key":"2024102100263690000_51.5.1702678.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01992-2016"},{"key":"2024102100263690000_51.5.1702678.76","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00463-2017"},{"key":"2024102100263690000_51.5.1702678.77","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00060414"},{"key":"2024102100263690000_51.5.1702678.78","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01208-2016"},{"key":"2024102100263690000_51.5.1702678.79","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00648-2017"},{"key":"2024102100263690000_51.5.1702678.80","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00387-2017"},{"key":"2024102100263690000_51.5.1702678.81","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00196712"},{"key":"2024102100263690000_51.5.1702678.82","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00705-2016"},{"key":"2024102100263690000_51.5.1702678.83","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0100"},{"key":"2024102100263690000_51.5.1702678.84","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0535"},{"key":"2024102100263690000_51.5.1702678.85","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0075"},{"key":"2024102100263690000_51.5.1702678.86","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0077OC"},{"key":"2024102100263690000_51.5.1702678.87","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00228-2017"},{"key":"2024102100263690000_51.5.1702678.88","doi-asserted-by":"crossref","first-page":"1601967","DOI":"10.1183\/13993003.01967-2016","article-title":"Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country","volume":"49","author":"Javaid","year":"2017","journal-title":"Eur Respir J"},{"key":"2024102100263690000_51.5.1702678.89","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00223-2017"},{"key":"2024102100263690000_51.5.1702678.90","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02309-2016"},{"key":"2024102100263690000_51.5.1702678.91","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00753-2017"},{"key":"2024102100263690000_51.5.1702678.92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-2600(16)30423-4","article-title":"Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis","volume":"5","author":"Kendall","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102100263690000_51.5.1702678.93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-2600(16)30432-5","article-title":"Effect of the short-course regimen on the global epidemic of multidrug-resistant tuberculosis","volume":"5","author":"Sotgiu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102100263690000_51.5.1702678.94","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00188313"},{"key":"2024102100263690000_51.5.1702678.95","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00103004"},{"key":"2024102100263690000_51.5.1702678.96","unstructured":"World Health Organization. Active tuberculosis drug-safety monitoring and management (aDSM). Framework for implementation. Geneva, World Health Organization, 2015."},{"key":"2024102100263690000_51.5.1702678.97","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01643-2017"},{"key":"2024102100263690000_51.5.1702678.98","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMc1603274","article-title":"Treatment outcomes in multidrug-resistant tuberculosis","volume":"375","author":"Gunther","year":"2016","journal-title":"N Engl J Med"},{"key":"2024102100263690000_51.5.1702678.99","unstructured":"World Health Organization. WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders. Geneva, World Health Organization, 2012."},{"key":"2024102100263690000_51.5.1702678.100","unstructured":"European Centre for Disease Prevention and Control. Management of contacts of MDRTB and XDR TB patients. Stockholm, ECDC, 2012."},{"key":"2024102100263690000_51.5.1702678.101","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann Intern Med"},{"key":"2024102100263690000_51.5.1702678.102","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00084310"},{"key":"2024102100263690000_51.5.1702678.103","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01414-2017"},{"key":"2024102100263690000_51.5.1702678.104","unstructured":"European Centre for Disease Prevention and Control. Guidance on tuberculosis control in vulnerable and hard-to-reach populations. Stockholm: ECDC, 2016."},{"key":"2024102100263690000_51.5.1702678.105","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00053012"},{"key":"2024102100263690000_51.5.1702678.106","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00079310"},{"key":"2024102100263690000_51.5.1702678.107","doi-asserted-by":"crossref","unstructured":"Woldehanna S , Volmink J . Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004; CD000171.","DOI":"10.1002\/14651858.CD000171.pub2"},{"key":"2024102100263690000_51.5.1702678.108","unstructured":"European Centre for Disease Prevention and Control. Investigation and control of tuberculosis incidents affecting children in congregate settings. Stockholm, ECDC, 2013."},{"key":"2024102100263690000_51.5.1702678.109","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00120908"},{"key":"2024102100263690000_51.5.1702678.110","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1881ED"},{"key":"2024102100263690000_51.5.1702678.111","unstructured":"World Health Organization. WHO policy on TB infection control in health - care facilities, congregate settings and households. Geneva, World Health Organization, 2009."},{"key":"2024102100263690000_51.5.1702678.112","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00029311"},{"key":"2024102100263690000_51.5.1702678.113","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/17476348.2016.1199278","article-title":"WHO strategies for the programmatic management of drug-resistant tuberculosis","volume":"10","author":"Matteelli","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"2024102100263690000_51.5.1702678.114","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5588\/pha.15.0060","article-title":"Tuberculosis infection control in health facilities in Lithuania: lessons learnt from a capacity support project","volume":"6","author":"Turusbekova","year":"2016","journal-title":"Public Health Action"},{"key":"2024102100263690000_51.5.1702678.115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.puhe.2015.10.031","article-title":"Strengthening TB infection control in specialized health facilities in Romania--using a participatory approach","volume":"131","author":"Turusbekova","year":"2016","journal-title":"Public Health"},{"key":"2024102100263690000_51.5.1702678.116","unstructured":"Schmidt BM . Tuberculosis interventions to prevent transmission of infection in health care workers: a systematic review. Thesis, Cape Town, University of Cape Town, 2014."},{"key":"2024102100263690000_51.5.1702678.117","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"2024102100263690000_51.5.1702678.118","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01578-2017"},{"key":"2024102100263690000_51.5.1702678.119","first-page":"640","article-title":"Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis","volume":"9","author":"Laserson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102100263690000_51.5.1702678.120","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00042908"},{"key":"2024102100263690000_51.5.1702678.121","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00956-2016"},{"key":"2024102100263690000_51.5.1702678.122","first-page":"878","article-title":"Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediate-incidence countries","volume":"12","author":"Heldal","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102100263690000_51.5.1702678.123","first-page":"236","article-title":"Guidance for the implementation of best practice for the care of patients with tuberculosis","volume":"12","author":"Williams","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102100263690000_51.5.1702678.124","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00044314"},{"key":"2024102100263690000_51.5.1702678.125","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02027-2017"},{"key":"2024102100263690000_51.5.1702678.126","unstructured":"World Health Organization. Framework for the engagement of all health care providers in the management of drug resistant tuberculosis. Geneva, World Health Organization, 2015."},{"key":"2024102100263690000_51.5.1702678.127","unstructured":"World Health Organization. Public-private mix for drug-resistant tuberculosis management: a situation assessment tool to engage all relevant care providers in drug-resistant tuberculosis (DR-TB) management at country level. Geneva, World Health Organization, 2015."},{"key":"2024102100263690000_51.5.1702678.128","unstructured":"World Health Organization. Public-Private Mix for TB care and control. A tool for national situation assessment. Geneva, World Health Organization, 2007."},{"key":"2024102100263690000_51.5.1702678.129","unstructured":"World Health Organization. Ethics guidance for the implementation of the End TB strategy. Geneva, World Health Organization, 2017."}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02678-2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:57:16Z","timestamp":1740380236000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02678-2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":129,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,17]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1183\/13993003.02678-2017"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02678-2017","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]}}}